3rd doses complete the initial vaccine series, occur at least 28 days after the 2nd dose and are available to immunocompromised individuals vaccinated with either PFR or MOD.
Booster doses are in addition to the completion of the initial vaccine series, occur at least 6 months after the 2nd dose, and are available to individuals vaccinated with PFR only who meet the criteria below:
People 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series.
People aged 50–64 years with underlying* medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series.
People aged 18–49 years with underlying* medical conditions may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.
People aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.
* Underlying medical conditions: Cancer, Chronic kidney disease, Chronic lung diseases (including COPD and asthma), Dementia, Diabetes (type 1 or type 2), Down syndrome, Heart conditions (such as heart failure, coronary artery disease, or hypertension), HIV infection, Immunocompromised state (weakened immune system), Liver disease, Overweight and obesity, Pregnancy, Sickle cell disease, Smoking (current or former), Solid organ or blood stem cell transplant, Stroke or cerebrovascular disease, Substance use disorders.
Note: This listed medical conditions do not include all potential medical conditions that could make you more likely to get severely ill. Rare medical conditions may not be included. However, a person with a condition that is not listed may still be in more danger from COVID-19 than persons of similar age who do not have the condition and should talk with their healthcare provider.
For more information regarding COVID-19, please visit the sites below:
NARMC: https://www.narmc.com/covid-19
CDC: https://www.cdc.gov/coronavirus